Diamond Therapeutics completes Period I medical research of reduced-dose psilocybin in nutritious human subjects (New Zealand's Ministry of Overseas Affairs and Trade, nonetheless, warns "there have been experiences of psychological harm, assault, theft and rape of individuals under the affect from the hallucinogen in ayahuasca tea and also deaths